<DOC>
	<DOCNO>NCT01135134</DOCNO>
	<brief_summary>This multicenter , randomize , parallel design , double-blind study mometasone furoate ( MF ) pediatric subject perennial allergic rhinitis . The subject 5 15 year age perennial allergic rhinitis enter no-treatment observation period 7 day minimum eligibility inclusion study assess . Following observation period , eligible subject randomize MF MF placebo 2-week double-blind treatment . At clinic visit ( start treatment 1 2 week treatment discontinuation ) , nasal symptom score , nasal finding , adverse event ( AEs ) , evaluate . A 30-day follow-up visit take place completion ( discontinuation ) 2-week treatment period , confirm presence absence serious adverse event ( SAEs ) trial procedure-related AEs .</brief_summary>
	<brief_title>Multicenter , Double-blind , Randomized , Placebo-controlled Study Mometasone Furoate Nasal Spray Pediatric Subjects With Perennial Allergic Rhinitis ( Study P06332 )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Pediatric subject perennial allergic rhinitis satisfy follow main criterion : Subjects symptoms perennial allergic rhinitis moderate severe degree , pretreatment observation period . Subjects confirm allergic nonseasonal environmental antigen ( e.g. , house dustmite antigen ) . Male female outpatient age 5 15 year time provide informed consent . Subjects main exclusion criterion applicable register study . Subjects coexist tuberculous disease lower respiratory tract infection subject nasopharyngolaryngeal infection ( acute upper respiratory tract infection , acute pharyngolaryngitis , acute tonsillitis , etc . ) require treatment time registration Subjects coexist infection systemic mycosis effective antibiotic Subjects repeat epistaxis Subjects nasal septum ulcer , nasal surgery , nasal trauma , heal Subjects severe hepatic , renal , cardiac , hematological disease , diabetes mellitus , hypertension , serious coexisting disease whose general condition poor Subjects complication vasomotor rhinitis eosinophilic rhinitis . Subjects nasal condition ( infectious sinusitis , hypertrophic rhinitis , acute chronic rhinitis , nasal polyp , septal deviation , etc . ) may interfere evaluation efficacy study drug .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>